PortViewPortView
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTXW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.00-0.00%
1-year price historyRange $0.00 – $0.17
52-week range$0.00
$0.00$0.06

What BriaCell Therapeutics Corp. does

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, currently in Phase 3, dedicated to revolutionizing cancer treatment through its innovative cellular immunotherapies. Its flagship product, Bria-IMT, is currently undergoing a pivotal Phase 3 clinical trial for advanced breast cancer, where it's being evaluated in combination with an immune checkpoint inhibitor. Beyond this lead candidate, the company is also advancing the development of personalized, off-the-shelf treatments designed to combat breast, prostate, and various other forms of cancer. Furthermore, BriaCell maintains a strategic partnership with Incyte Corporation, focused on further evaluating Bria-IMT in combination therapies. The company's operations are headquartered in West Vancouver, Canada.

Key metrics

Market cap
$1,695
P/E (TTM)
-0.00
EPS (TTM)
$-1,396.25
Beta
2.03
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.03
200-day avg
$0.05
52-week high
$0.06
52-week low
$0.00
CEO
William V. Williams

ETFs linked to BCTXW

Broad-market and Healthcare sector ETFs an investor holding BriaCell Therapeutics Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BCTXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BCTXW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for BriaCell Therapeutics Corp.?
BriaCell Therapeutics Corp. trades under the ticker BCTXW on NASDAQ.
Which exchange is BCTXW listed on?
BCTXW is listed on NASDAQ.
What sector does BriaCell Therapeutics Corp. operate in?
BriaCell Therapeutics Corp. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BCTXW in a portfolio?
PortView shows BCTXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.